A reengineered common chain cytokine augments CD8+ T cell–dependent immunotherapy

Anirban Banerjee(University of Maryland, Baltimore), Alexander S. Krupnick(University of Maryland, Baltimore)
JCI Insight
May 22, 2022
Cited by 4


Related Papers